BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17630485)

  • 1. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
    Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A
    Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
    Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
    Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
    Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese.
    Chen CH; Lo YK; Ke D; Liu CK; Liou CW; Wu HL; Lai ML;
    J Neurol Sci; 2004 Dec; 227(1):1-5. PubMed ID: 15546585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet glycoprotein polymorphisms: risk, in vivo expression and severity of atherothrombotic stroke in Chinese.
    Zhang Y; Wang Y; Wang Y; Cui C; Huang P; Li X; Liu S; Lendon C; Guo N
    Clin Chim Acta; 2007 Mar; 378(1-2):99-104. PubMed ID: 17196570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
    Addad F; Elalamy I; Chakroun T; Abderrazek F; Dridi Z; Hamdi S; Hassine M; Ben-Farhat M; Gerotziafas G; Hatmi M; Gamra H
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):674-8. PubMed ID: 20739877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
    Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
    Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable number of tandem repeats polymorphism of platelet glycoprotein Ib alpha in Chinese people and CC genotype with aspirin sensitivity in patients with cerebral infarction.
    Jin YY; Yu GZ; Wang Y; Cui LY; Xin XM
    J Clin Pharm Ther; 2009 Apr; 34(2):239-43. PubMed ID: 19250145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.
    Godeneche G; Sorel N; Ragot S; Chomel JC; Neau JP; Macchi L
    Platelets; 2009 Nov; 20(7):471-7. PubMed ID: 19852685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 807C/T polymorphism in the platelet glycoprotein Ia gene in young patients with ischemic stroke of undetermined etiology.
    de Oliveira MH; André C; Spector N; Luiz RR; de Castro Souza G; Gadelha T
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):599-602. PubMed ID: 17890945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes.
    Pellitero S; Reverter JL; Tàssies D; Pizarro E; Monteagudo J; Salinas I; Aguilera E; Sanmartí A; Reverter JC
    Thromb Haemost; 2010 Mar; 103(3):630-7. PubMed ID: 20076847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Platelet glycoprotein IIb/IIIa (LeuPro 33) polymorphism in stroke patients].
    Pongrácz E; Tordai A; Csornai M; Nagy Z
    Orv Hetil; 2001 Apr; 142(15):781-5. PubMed ID: 11367863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients.
    Lanni F; Santulli G; Izzo R; Rubattu S; Zanda B; Volpe M; Iaccarino G; Trimarco B
    J Hypertens; 2007 Mar; 25(3):551-6. PubMed ID: 17278970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of C807T, Pl(A), and -5 C/T Kozak genotypes with density of glycoprotein receptors on platelet surface.
    Huang T; Sahud MA
    Thromb Res; 2003; 112(3):147-50. PubMed ID: 14967411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.
    Weiss EJ; Bray PF; Tayback M; Schulman SP; Kickler TS; Becker LC; Weiss JL; Gerstenblith G; Goldschmidt-Clermont PJ
    N Engl J Med; 1996 Apr; 334(17):1090-4. PubMed ID: 8598867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VNTR polymorphism in intron 4 of the eNOS gene and the risk of ischemic stroke in a South Indian population.
    Munshi A; Rajeshwar K; Kaul S; Chandana E; Shafi G; Anila AN; Balakrishna N; Alladi S; Jyothy A
    Brain Res Bull; 2010 Jul; 82(5-6):247-50. PubMed ID: 20472037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors responsible for "aspirin resistance" - can we identify them?
    Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G
    Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.